Literature DB >> 26790559

Orbital wall infarction in child with sickle cell disease.

C Janssens1, L Claeys, P Maes, T Boiy, M Wojciechowski.   

Abstract

We present the case of a 17-year-old boy, known with homozygous sickle cell disease, who was admitted because of generalised pain. He developed bilateral periorbital oedema and proptosis, without pain or visual disturbances. In addition to hyperhydration, oxygen and analgesia IV antibiotics were started, to cover a possible osteomyelitis. Patients with sickle cell disease are at risk for vaso-occlusive crises, when the abnormally shaped red blood cells aggregate and block the capillaries. Such a crisis typically presents at a location with high bone marrow activity, as the vertebrae and long bones. At an early age, the bone marrow is still active at other sites, for example the orbital wall, and thus infarction can also occur there. Thus, in young persons with sickle cell disease, it is important to consider orbital wall infarction in the differential diagnosis, since the approach is different from osteomyelitis. If the disease is complicated by an orbital compression syndrome, corticosteroids or surgical intervention may be necessary to preserve the vision. In our patient, an MRI of the orbitae demonstrated periorbital oedema with bone anomalies in the orbital and frontal bones, confirming orbital wall infarction. Ophthalmological examination revealed no signs of pressure on the nervus opticus. The patient recovered gradually with conservative treatment.

Entities:  

Keywords:  Orbital wall infarction; Sickle cell disease

Mesh:

Year:  2015        PMID: 26790559     DOI: 10.1080/17843286.2015.1107206

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  2 in total

1.  Orbital Infarction due to Sickle Cell Disease without Orbital Pain.

Authors:  Cameron L McBride; Kim-Binh T Mai; Kartik S Kumar
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-07

2.  Recurrent orbital bone sub-periosteal hematoma in sickle cell disease: a case study.

Authors:  Abdulhamid Alghamdi
Journal:  BMC Ophthalmol       Date:  2018-08-28       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.